15 results about "Medium chain fatty acid" patented technology

The present invention relates to a composition for preventing and treating viral infection of the family of African swine fever viruses, in particular, a composition for treating, inhibiting and / or preventing viral infection of the family of African swine fever viruses (Asfaraviridae), preferably African swine fever virus, characterized in that the composition comprises one or more medium-chain fatty acids (MCFAs) and / or derivatives thereof.

This invention relates to ketogenic nutritional powder containing medium- and long-chain fatty acid triglycerides, its preparation method, and its application. It belongs to the field of food science and engineering technology. It uses enzymatically synthesized medium- and long-chain fatty acid triglyceride structured lipids as the sole fat source, which is different from the traditional physical mixture of long-chain triglycerides and medium- and long-chain oils. Medium-chain fatty acids and long-chain fatty acids are simultaneously bound to the same glycerol molecule. Fatty acid digestion and absorption are synchronized and metabolized, which can give full play to the synergistic nutritional advantages. It retains the characteristics of medium-chain fatty acids that provide rapid energy and are not easy to accumulate in body fat, while also supplementing essential fatty acids such as linoleic acid and α-linolenic acid. At the same time, it overcomes the disadvantages of pure medium-chain fatty acid oils that cause great gastrointestinal irritation and have a low smoke point.

An object of the present application is to provide a new composition for promoting ketogenesis. According to the present application, there is provided a composition for promoting ketogenesis containing one or two or more amino acids selected from the group consisting of citrulline, leucine, cysteine, taurine, glutamine and aspartic acid. The composition of the present application can further contain either or both of a medium-chain fatty acid and a medium-chain fatty acid ester.

The present invention addresses the problem of providing technology that can reduce off-flavors derived from free medium-chain fatty acids in aqueous-phase-containing foods containing triglycerides that contain medium-chain fatty acids as constituent fatty acids.　The present invention provides a food composition, said food composition comprising an oil phase and aqueous phase and comprising a prescribed amount of one or more components selected from the group consisting of allyl isothiocyanate, 1-hexanol, 2-heptanone, and butyric acid, wherein the oil phase contains a medium-chain fatty acid, and the medium-chain fatty acid is in the form of a triglyceride constituent fatty acid and / or in the form of a free medium-chain fatty acid.

The application belongs to the technical field of biological medicine, and particularly relates to a medium-chain fatty acid composition for improving immunity of calves and a preparation method thereof. The medium-chain fatty acid composition for improving immunity of calves according to the application comprises, in terms of weight fractions, 20-30 parts of lactose, 5-10 parts of medium-chain fatty acid, 1-3 parts of mangiferin derivative, 0.5-2 parts of wedelolactone and 0.2-1 part of vitamin C. The mangiferin derivative according to the application can relieve local inflammatory reaction of the intestinal tract, repair the intestinal mucosal barrier damaged by stress, and enhance the non-specific immune capacity of the body. The wedelolactone according to the application forms a double synergy with the lactose and the medium-chain fatty acid, greatly improves the utilization efficiency of energy and nutrients, and thus promotes the growth and development of the calf. In addition, the wedelolactone can also synergize with the mangiferin derivative, maintains the intestinal health of the calf in the early weaning period, and significantly weakens the weaning stress impact.

The present application belongs to the technical field of enteral nutrition preparation, and particularly relates to an enteral nutrition supplement for hyperlipidemia, a preparation method and application thereof. The enteral nutrition supplement comprises the following raw materials: medium-chain triglyceride, camellia chrysanthemum culture and cherry blossom polyphenol, and further comprises protein 15-25 parts, carbohydrate 40-50 parts, compound vitamin 0.01-0.05 parts and mineral 1-5 parts. The prepared enteral nutrition supplement is composed of a fat system completely formed by medium-chain fatty acid ester, and the blood fat is improved by synergistic effect of the camellia chrysanthemum culture and the cherry blossom polyphenol, so as to solve the application problem of traditional long-chain fat nutrition support under specific pathological conditions such as fatty liver, chylous fistula and chronic pancreatitis.

The present application relates to the technical field of livestock feed, and discloses a low-protein feed preparation method for laying hens based on net energy and mineral regulation, which comprises a basic daily ration, a natural intestinal health promoting mineral compound and a functional additive, the basic daily ration is set to a low net energy level, and the sodium-potassium-chlorine electrolyte balance value is strictly controlled, the compound lipid emulsified energy source microcapsule powder in the functional additive releases medium-chain fatty acids in the early stage of the intestinal tract, and the medium-chain fatty acids are absorbed synchronously with free amino acids to improve the utilization rate of crude protein and reduce the corruption of the posterior intestinal tract, activated montmorillonite and natural clinoptilolite are used to cooperatively regulate the osmotic pressure of the intestinal tract, reduce the incidence of watery feces and ammonia emission, L-cystine is crosslinked in the oviduct to form a disulfide bond network skeleton, the expansion effect of selenium-rich tourmaline powder on microvessels is combined, the compression strength of the eggshell and the selenium content of the yolk are effectively improved, and the present application significantly reduces the feed-to-egg ratio, improves the intestinal health and the quality of the end product.

The present disclosure provides an application of a medium-chain fatty acid mixed structural lipid in improving diet-induced disorders of glucose (Glu) and lipid metabolism. The medium-chain fatty acid mixed structural lipid includes capric lauric triglyceride and capric lauric diglyceride, and a mass percentage content ratio of capric acid to lauric acid in the medium-chain fatty acid mixed structure lipid is 1:1-1:4. In the present disclosure, it is found that adding medium-chain fatty acid mixed glyceride rich in lauric acid into high-energy feed can improve diet-induced disorders of Glu and lipid metabolism, including but not limited to reducing a serum Glu level, improving Glu homeostasis, reducing a serum low density lipoprotein cholesterol (LDL-C) level and improving expressions of genes related to Glu and lipid metabolism.

Silane compounds derived from medium-chain fatty acids are generally disclosed herein. Methods of using such compounds, for example, as compatibilizing agents, are also disclosed herein, as well as methods of making such compounds, for example, from medium-chain fatty acids derived from natural oils.

This invention discloses a method for efficiently producing medium-chain fatty acids using anaerobic fermentation of fruit and vegetable organic waste, comprising: S1: collecting fruit and vegetable organic waste and crushing it to obtain a mixed liquid of fruit and vegetable organic waste; S2: acclimating sludge: taking sludge from a sewage treatment plant, acclimating it, and setting it aside for later use; S3: fermentation treatment: placing the mixed liquid of fruit and vegetable organic waste obtained in S1 into a fermentation container and adding the acclimated sludge, and fermenting in an anaerobic environment; S4: adding the mixed liquid of fruit and vegetable organic waste every 6 days during the reaction period from 0 to 24 days, with a feeding rate of 1 / 3; S5: adding the mixed liquid of fruit and vegetable organic waste every 6 days during the reaction period from 25 to 42 days, with a feeding rate of 1 / 4; S6: adding the mixed liquid of fruit and vegetable organic waste every 6 days during the reaction period from 43 to 60 days, with a feeding rate of 1 / 5; S7: collecting medium-chain fatty acids. This invention makes full use of the organic resources in kitchen waste, achieving deep waste treatment while promoting the production efficiency and yield of medium-chain fatty acids.

Abstract: This patent establishes a chemical synthesis method for preparing structured oils by transesterification of low-carbon fatty acid alcohol esters and triglycerides, including the synthesis of various structured oils such as medium-chain triglycerides, short-chain triglycerides, and medium-to-long-chain triglycerides. The prepared medium-chain triglycerides, short-chain triglycerides, and medium-to-long-chain triglycerides are then scientifically formulated to form structured oils with specific functions, applicable to medical, health, and functional food applications.

The application discloses an anti-fatigue plant source nutritional supplement containing total paeony glycosides and a preparation method thereof. The nutritional supplement comprises a total paeony glycoside derivative modified by enzymatic selective acylation, vitamins and minerals, and a compound of acanthopanax senticosus extract, astragalus extract, medlar extract and grape seed extract. The total paeony glycoside derivative is selectively modified by introducing a C4-C8 medium-chain fatty acid acyl group to the C-6' hydroxyl group of paeonoside. The application significantly improves the fat solubility and membrane permeability of the total paeony glycoside by using a green and mild enzymatic acylation technology, so that the apparent permeability coefficient is increased by 8-12 times. The nutritional supplement prolongs the weight-bearing swimming time of mice by 92.8%, significantly reduces the serum urea nitrogen and blood lactic acid levels, increases the blood lactic acid elimination ratio to 37.8%, activates the AMPK-PGC1 alpha energy metabolism pathway and adjusts the central nervous transmitter 5-HT / DA ratio, and has a synergistic anti-fatigue effect.

This disclosure discloses a core-shell encapsulated medium-chain fatty acid salt, wherein (i) the core comprises at least one of an alkali metal salt of a medium-chain fatty acid or a saprolizumab-functionalized medium-chain fatty acid salt; and (ii) the shell comprises at least one of an alkali metal salt of a medium-chain fatty acid encapsulating the core or a saprolizumab-functionalized medium-chain fatty acid salt. The use of such encapsulated acid in pharmaceutical compositions is also disclosed, particularly in oral solid dosage forms such as tablets. The tablets of this disclosure exhibit excellent mechanical properties.

The present application relates to the technical field of external preparation preparation, and discloses a kind of nano-dispersed composition for external use prevention and treatment hair follicle related pathogenic microorganism.The composition comprises free octanoic acid 0.1-1.5%, free decanoic acid 0.1-1.5%, free lauric acid 0.1-1.5%, polyoxyethylene hydrogenated castor oil 3-10% and polyol solvent 5-20% by total weight of composition.The pH of the composition is 3.0-5.0, the particle size is 20-100 nm, and PDI≤0.3.The composition remains clear and transparent after 3 freeze-thaw cycles at-20℃ / 4℃, and exhibits synergistic antibacterial effect on hair follicle related pathogenic microorganisms such as malassezia furfur, propionibacterium acnes and staphylococcus aureus at a lower active ingredient dosage.The ternary medium-chain fatty acid nano-dispersed system of the present application has synergistic antibacterial effect and low-temperature stability, and can be used to prepare external preparations for regulating hair follicle skin microecology, inhibiting excessive proliferation of hair follicle related microorganisms or preventing and treating acne, folliculitis, malassezia related skin problems and dandruff related problems.

A pharmaceutical composition for preventing an aortic aneurysm is provided including a medium chain fatty acid as a main component, which has an effect of inhibiting the occurrence and progression of the aortic aneurysm. Thus, when the aortic aneurysm is found, the composition through continuous intake can exhibit effects including inhibition of the progression of the aortic aneurysm and improvement in the vital prognosis.